Stakeholders' preferences and the assessment of forest ecosystem services: a comparative analysis in Italy

Autor: A. Paletto, G. Giacovelli, G. Grilli, J. Balest, I. De Meo

Publikováno v: Journal of Forest Science, Vol 60, Iss 11, Pp 472-483 (2014)

Values are qualities and beliefs orientating human actions and they change according to socio-economic variables such as gender, culture, education and income. Incorporating stakeholders' values and attitudes in the forest planning is essential for r

Externí odkaz: https://doaj.org/article/f5ea81462b944cba8f000a2ff6394084

Ecosystem services in forests of Calabria: stakeholders’ perception

Autor: Vivona, P Paletto, P Pellicone, G Giacovelli, M Maesano, M Matteucci, S M Scarascia Mugnozza, Veltri, P Pastorella

Publikováno v: Forest@, Vol 14, Iss 1, Pp 143-161 (2017)

In the last decades, the ecological, economic and social analysis of benefits provided by ecosystem to society has coved a great importance in the scientific international literature. The main studies focuses on three aspects: ecosystem services pote

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::476073fb73a4872f90f813bac67f7d57
http://foresta.sisef.org/contents/?id=efor2219-014&lang=en

AB0360 EFFICACY AND SAFETY OF THE PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST CR6086 ADDED TO METHOTREXATE IN DMARD-NAÏVE EARLY RA PATIENTS: A PHASE 2 RANDOMIZED CONTROLLED TRIAL

Autor: M. Krogulec, Massimo D'Amato, Minodora Mazur, Peter C. Taylor, A. R. Bihlet, G. Giacovelli, Olga Kubassova, R. Østgård, Lucio C. Rovati, F. Girolami, Karel Pavelka, I. D. Delina

Publikováno v: Annals of the Rheumatic Diseases. 79:1480.1-1481

Background:MTX is the first line treatment in early RA. There is robust evidence from cohort studies, but less from RCTs, that a “window of opportunity” exists over 12-16 weeks symptom duration. CR6086 is a selective prostaglandin EP4 receptor an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f781b56713a38454e7c57f5ba035185d
https://doi.org/10.1136/annrheumdis-2020-eular.5636

Republished: Value of biomarkers in osteoarthritis: current status and perspectives

Autor: Martin Lotz, René Rizzoli, Johanne Martel-Pelletier, Jean-Pierre Pelletier, S. Reiter-Niesert, G. Giacovelli, Olivier Bruyère, Cyrus Cooper, Morten A. Karsdal, Roland Chapurlat, Claus Christiansen, Jean-Yves Reginster, W.E. van Spil, Virginia B. Kraus, Willem F. Lems, Linda J. Sandell, John A. Kanis, Jacques Raynauld, Ingrid Meulenbelt, Julien Collette, Maria Luisa Brandi

Publikováno v: Lotz, M, Martel-Pelletier, J, Christiansen, C, Brandi, M L, Bruyere, O, Chapurlat, R, Collette, J, Cooper, C, Giacovelli, G, Kanis, J, Karsdal, M, Kraus, V, Lems, W F, Meulenbelt, I, Pelletier, J P, Raynauld, J P, Reiter-Niesert, S, Rizzoli, R, Sandell, L, Van Spil, W & Reginster, J Y 2014, ' Republished: Value of biomarkers in osteoarthritis: current status and perspectives ', Postgraduate Medical Journal, vol. 90, no. 1061, pp. 171-178 . https://doi.org/10.1136/postgradmedj-2013-203726rep
Postgraduate Medical Journal
Postgraduate Medical Journal, 90(1061), 171-178. BMJ Publishing Group
Postgraduate Medical Journal, Vol. 90, No 1061 (2014) pp. 171-178

Osteoarthritis affects the whole joint structure with progressive changes in cartilage, menisci, ligaments and subchondral bone, and synovial inflammation. Biomarkers are being developed to quantify joint remodelling and disease progression. This art

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e15d5fb8f8e8df70168f302ab9e86b
https://doi.org/10.1136/postgradmedj-2013-203726rep

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.